 ResMed Inc. NYSE:RMD Q1 2023 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Amy Wakeham - VP, IR Corporate Communications Mick Farrell - CEO Director Brett Sandercock - CFO Rob Douglas - President, COO and Interim President, Sleep Respiratory Care David Pendarvis - Chief Administrative Officer and Global General Counsel Conference Call Participants Steve Wheen - Jarden Matt Mishan - KeyBanc Gretel Janu - Credit Suisse Saul Hadassin - Barrenjoey Capital Dan Hurren - MST Marquee Mike Matson - Needham David Bailey - Macquarie Lyanne Harrison - Bank of America Craig Wong-Pan - RBC Chris Cooper - Goldman Sachs Suraj Kalia - Oppenheimer Margaret Kaczor - William Blair Mathieu Chevrier - Citi Steve Wheen - Jarden Limited Operator Hello, and welcome to the ResMed First Quarter Fiscal 2023 Earnings Call. At this time, all participants are in a listen-only mode. 